[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 403
Citations 0
Correction
June 27, 2012

Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’

JAMA. 2012;307(24):2590. doi:10.1001/jama.2012.6832

Error in Viewpoint: In the Viewpoint entitled “Statin Therapy for Healthy Men Identified as ‘Increased Risk,’” published in the April 11, 2012, issue of JAMA (2012;307[4]:1489-1490), the first sentence of the fourth paragraph presented data from the AFCAPS/TexCAPS trial incorrectly. The sentence should have read, “Similarly, the AFCAPS/TexCAPS randomized 6605 asymptomatic adults with a mean (SD) LDL-C level of 150 (17) mg/dL and low HDL-C (36 [5] mg/dL in men and 40 [5] mg/dL in women) to lovastatin, 20 to 40 mg, vs placebo.” This article was corrected online.

×